CardiAQ Says $23M Is Minimum Fair Boost To $70M IP Verdict
After winning a $70 million trade secrets verdict against medical device maker Neovasc, rival CardiAQ told a federal court on Thursday that the verdict should be enhanced by at least $23.3...To view the full article, register now.
Already a subscriber? Click here to view full article